HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2112764Generated: November 1, 2026
Chloroform → 2-[(4-Methylpiperazin-1-yl)methyl]morpholine
https://huagongshe.com/reaction/2112764
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Chloroform | HCID 6212 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Aluminium lithium hydride | HCID 21226445 | — |
| Reactant | Tert-butyl 4-(morpholin-2-ylmethyl)piperazine-1-carboxylate | HCID 23079694 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 2-[(4-Methylpiperazin-1-yl)methyl]morpholine | HCID 14627568 | 66% |
Reaction Steps
Lithium aluminum hydride (150 mg, 4.10 mmol) was suspended in tetrahydrofuran (5 mL), and the suspension was mixed with a solution of tert-butyl 4-morpholin-2-ylmethylpiperazinecarboxylate (390 mg, 1.37 mmol) prepared as an intermediate according to Process Step 2 of Reference Example 19 in tetrahydrofuran (5 mL) added dropwise under ice-cooling, followed by heating at 60° C. under reflux for two hours. An aqueous sodium hydroxide solution (2 mol/L, 10 mL) and chloroform (50 mL) were added under ice-cooling, followed by separation. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure, to thereby yield the title compound (180 mg, in a yield of 66%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07524852B2 |
|---|
| Source dataset | uspto-grants-2009_04 |
|---|
| ORD ID | ord-fe6286ce9ecd46428d1b775860ddaf95 |
|---|
| Source note | uspto-grants-2009_04 |
|---|